Start Over

[Digital Health in Rheumatology - Status 2018/19].

Authors :: Richter JG
Chehab G
Kiltz U
Callhoff J
Voormann A
Lorenz HM
Schneider M
Specker C
Source :: Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2019 Apr; Vol. 144 (7), pp. 464-469. Date of Electronic Publication: 2019 Mar 29.
Publication Year :: 2019
Abstract: State of the Art: Innovations in information and communication technology have been used in rheumatology for many years. In 2018 the German Society for Rheumatology established the Commission "Digital Rheumatology".<br />Digital Applications in German Rheumatology: Mobile data acquisition in rheumatological patients is feasible. It offers innovative possibilities in the implementation of modern treatment strategies. Digital applications such as the "Rheuma Check" and the "Bechterew Check" are available to the public at any time to screen for inflammatory rheumatic diseases. Other digital services and modern networks allow a triage of patients. Rhekiss and RABBIT SpA are the first fully digitalised registries to provide short-term data on issues that are not covered by clinical trials of pharmaceutical companies.<br />Outlook: Digitalization in Rheumatology will provide much faster answers to important questions in healthcare research in the future.<br />Competing Interests: Die Poliklinik, Funktionsbereich & Hiller Forschungszentrum für Rheumatologie (Prof. Dr. M. Schneider, Prof. Dr. J.G. Richter, Dr. G. Chehab) erhält/erhielt für die folgenden Projekte finanzielle Unterstützung: Lupus-Langzeit-(LuLa-)Studie (GlaxoSmithKline, UCB Pharma GmbH), MiDEAR (UCB Pharma GmbH) und RheumaCheck (Abbvie Deutschland).Dr. Kiltz erhielt Berater- und/oder Referentenhonorare durch die Firmen AbbVie, Chugai, Eli Lilly, Grünenthal, Janssen, MSD, Novartis, Pfizer, Roche and UCB. Forschungsunterstützung (unrestricted grant) durch Abbvie, Biogen, Novartis und Pfizer.Die anderen Autoren geben an, dass keine Interessenkonflikte bestehen.<br /> (© Georg Thieme Verlag KG Stuttgart · New York.)